BrainLAB Announces 510(k) FDA Clearance of Monte Carlo Dose Engine for Stereotactic Radiosurgery and Radiati...(head & neck sites. It is clearlya much n...),Health

This powerful dose calculation engine provides an advanced level of integration, which means its use is not limited to a single machine, multi-leaf collimator, energy or treatment modality and can be seamlessly integrated to drive treatment with Varian, Siemens, and Elekta MLCs and linear accelerators. The multitude of treatment plans supported by the Monte Carlo Dose Calculation Algorithm, which include conformal beam, static and dynamic arc, and IMRT treatment modalities, makes it a powerful solution for radiotherapy today and the future.

"We believe that the release of the BrainLAB Monte Carlo Dose Calculation Algorithm will have a great impact on the field of radiosurgery. We continue to develop software solutions that extend clinicians' treatment precision to cover more extra-cranial cancers as well as advanced dose calculation possibilities for lung and head & neck tumors," said David J. Brett, Product Manager iPlan Oncology, BrainLAB.

The Monte Carlo Dose Algorithm was developed by physicist Matthias Fippel, Ph.D., Senior Software Engineer at BrainLAB, who has published numerous clinical papers on the subject over the past 10 years. Fippel is seen to be one of the foremost experts in the field and previously worked on Monte Carlo research projects at the University of Leipzig and the University of Tubingen in Germany. The Monte Carlo Dose Calculation Algorithm is based on the XVMC (X-Ray Voxel Monte Carlo) algorithm and has been verified using the widely respected EGSnrc and BEAMnrc software algorithms. The advanced dose calculation solution from BrainLAB is based on the Monte Carlo method of modeling the transport of radiation through a beam collimation system (micro multi-leaf collimator, or MLC) and through
'/>"/>